(Reuters) - Schering-Plough made the comments on a conference call with
analysts to discuss its second-quarter results.
Earlier, the drugmaker said quarterly earnings rose
sharply, fueled by growing demand for its drugs for
cholesterol, arthritis and allergies.
Read more at Reuters.com Market News
analysts to discuss its second-quarter results.
Earlier, the drugmaker said quarterly earnings rose
sharply, fueled by growing demand for its drugs for
cholesterol, arthritis and allergies.
Read more at Reuters.com Market News
No comments:
Post a Comment